Stoke Therapeutics Inc diskutieren
Stoke Therapeutics Inc
WKN: A2PLTL / Symbol: STOK / Name: Stoke Therapeutics / Aktie / Biotechnologie & medizinische Forschung / ? /
11,00 €
-1,74 %
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Neueste Beiträge
StockNews_com in A10 Networks diskutieren